nodes	percent_of_prediction	percent_of_DWPC	metapath
Metoclopramide—HTR3A—schizophrenia	0.268	0.335	CbGaD
Metoclopramide—CHRM1—schizophrenia	0.2	0.25	CbGaD
Metoclopramide—DRD3—schizophrenia	0.153	0.191	CbGaD
Metoclopramide—DRD2—schizophrenia	0.106	0.132	CbGaD
Metoclopramide—CYP2D6—schizophrenia	0.0746	0.0932	CbGaD
Metoclopramide—DRD3—telencephalic ventricle—schizophrenia	0.00701	0.133	CbGeAlD
Metoclopramide—CYP11B2—blood plasma—schizophrenia	0.00482	0.0914	CbGeAlD
Metoclopramide—HTR4—telencephalon—schizophrenia	0.00431	0.0817	CbGeAlD
Metoclopramide—DRD2—telencephalic ventricle—schizophrenia	0.00296	0.0562	CbGeAlD
Metoclopramide—HTR4—brain—schizophrenia	0.00194	0.0369	CbGeAlD
Metoclopramide—CYP11B2—blood—schizophrenia	0.00177	0.0335	CbGeAlD
Metoclopramide—CYP11B1—blood—schizophrenia	0.00177	0.0335	CbGeAlD
Metoclopramide—CYP2D6—urine—schizophrenia	0.00163	0.0308	CbGeAlD
Metoclopramide—CYP11B2—endocrine gland—schizophrenia	0.00153	0.029	CbGeAlD
Metoclopramide—CYP11B1—endocrine gland—schizophrenia	0.00153	0.029	CbGeAlD
Metoclopramide—HTR3A—forebrain—schizophrenia	0.00127	0.024	CbGeAlD
Metoclopramide—CYP17A1—gonad—schizophrenia	0.00124	0.0235	CbGeAlD
Metoclopramide—HTR3A—telencephalon—schizophrenia	0.00116	0.0221	CbGeAlD
Metoclopramide—DRD3—nervous system—schizophrenia	0.000993	0.0188	CbGeAlD
Metoclopramide—CHRM1—forebrain—schizophrenia	0.000961	0.0182	CbGeAlD
Metoclopramide—DRD3—central nervous system—schizophrenia	0.000956	0.0181	CbGeAlD
Metoclopramide—CYP17A1—endocrine gland—schizophrenia	0.000935	0.0177	CbGeAlD
Metoclopramide—CHRM1—telencephalon—schizophrenia	0.000884	0.0168	CbGeAlD
Metoclopramide—CYP17A1—nervous system—schizophrenia	0.000875	0.0166	CbGeAlD
Metoclopramide—CYP2D6—blood plasma—schizophrenia	0.000849	0.0161	CbGeAlD
Metoclopramide—HTR3A—blood—schizophrenia	0.000846	0.016	CbGeAlD
Metoclopramide—CYP17A1—central nervous system—schizophrenia	0.000843	0.016	CbGeAlD
Metoclopramide—DRD2—forebrain—schizophrenia	0.000774	0.0147	CbGeAlD
Metoclopramide—DRD3—brain—schizophrenia	0.000759	0.0144	CbGeAlD
Metoclopramide—DRD2—telencephalon—schizophrenia	0.000712	0.0135	CbGeAlD
Metoclopramide—HTR3A—nervous system—schizophrenia	0.000687	0.013	CbGeAlD
Metoclopramide—Bromopride—DRD2—schizophrenia	0.000686	0.106	CrCbGaD
Metoclopramide—CYP17A1—brain—schizophrenia	0.000669	0.0127	CbGeAlD
Metoclopramide—HTR3A—central nervous system—schizophrenia	0.000661	0.0125	CbGeAlD
Metoclopramide—Chloroprocaine—HTR3A—schizophrenia	0.000644	0.0993	CrCbGaD
Metoclopramide—Procaine—HTR3A—schizophrenia	0.000614	0.0948	CrCbGaD
Metoclopramide—CHRM1—endocrine gland—schizophrenia	0.000558	0.0106	CbGeAlD
Metoclopramide—Amisulpride—HTR7—schizophrenia	0.000554	0.0854	CrCbGaD
Metoclopramide—Cisapride—HTR3A—schizophrenia	0.000547	0.0845	CrCbGaD
Metoclopramide—HTR3A—brain—schizophrenia	0.000525	0.00995	CbGeAlD
Metoclopramide—CHRM1—nervous system—schizophrenia	0.000522	0.00989	CbGeAlD
Metoclopramide—Amisulpride—DRD3—schizophrenia	0.00052	0.0803	CrCbGaD
Metoclopramide—DRD2—midbrain—schizophrenia	0.000511	0.00969	CbGeAlD
Metoclopramide—CHRM1—central nervous system—schizophrenia	0.000502	0.00952	CbGeAlD
Metoclopramide—CYP2D6—forebrain—schizophrenia	0.000465	0.00882	CbGeAlD
Metoclopramide—Procainamide—DNMT1—schizophrenia	0.000464	0.0716	CrCbGaD
Metoclopramide—DRD2—endocrine gland—schizophrenia	0.000449	0.00851	CbGeAlD
Metoclopramide—CYP2D6—telencephalon—schizophrenia	0.000428	0.00811	CbGeAlD
Metoclopramide—DRD2—nervous system—schizophrenia	0.00042	0.00797	CbGeAlD
Metoclopramide—DRD2—central nervous system—schizophrenia	0.000405	0.00767	CbGeAlD
Metoclopramide—CHRM1—brain—schizophrenia	0.000399	0.00756	CbGeAlD
Metoclopramide—DRD2—cerebellum—schizophrenia	0.000395	0.0075	CbGeAlD
Metoclopramide—Amisulpride—DRD2—schizophrenia	0.00036	0.0556	CrCbGaD
Metoclopramide—Chloroprocaine—SLC6A3—schizophrenia	0.000341	0.0527	CrCbGaD
Metoclopramide—Procaine—SLC6A3—schizophrenia	0.000326	0.0502	CrCbGaD
Metoclopramide—DRD2—brain—schizophrenia	0.000321	0.00609	CbGeAlD
Metoclopramide—CYP2D6—blood—schizophrenia	0.000311	0.0059	CbGeAlD
Metoclopramide—Amisulpride—HTR2A—schizophrenia	0.000278	0.0429	CrCbGaD
Metoclopramide—CYP2D6—endocrine gland—schizophrenia	0.00027	0.00511	CbGeAlD
Metoclopramide—Cisapride—HTR2C—schizophrenia	0.000262	0.0404	CrCbGaD
Metoclopramide—CYP2D6—nervous system—schizophrenia	0.000253	0.00479	CbGeAlD
Metoclopramide—CYP2D6—central nervous system—schizophrenia	0.000243	0.00461	CbGeAlD
Metoclopramide—CYP2D6—cerebellum—schizophrenia	0.000238	0.0045	CbGeAlD
Metoclopramide—Cisapride—DRD2—schizophrenia	0.000216	0.0333	CrCbGaD
Metoclopramide—Cisapride—CYP1A2—schizophrenia	0.000198	0.0305	CrCbGaD
Metoclopramide—CYP2D6—brain—schizophrenia	0.000193	0.00366	CbGeAlD
Metoclopramide—Cisapride—HTR2A—schizophrenia	0.000167	0.0257	CrCbGaD
Metoclopramide—Cisapride—CYP2D6—schizophrenia	0.000152	0.0235	CrCbGaD
Metoclopramide—Procainamide—CYP2D6—schizophrenia	8.86e-05	0.0137	CrCbGaD
Metoclopramide—Sunitinib—ABCB1—schizophrenia	6.47e-05	0.00999	CrCbGaD
Metoclopramide—DRD2—Signaling Pathways—NGEF—schizophrenia	1.62e-05	0.000115	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—HTR1A—schizophrenia	1.62e-05	0.000115	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—NPY—schizophrenia	1.61e-05	0.000115	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—NDST3—schizophrenia	1.61e-05	0.000115	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism of lipids and lipoproteins—EP300—schizophrenia	1.61e-05	0.000114	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—NRG3—schizophrenia	1.61e-05	0.000114	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—TLE1—schizophrenia	1.61e-05	0.000114	CbGpPWpGaD
Metoclopramide—DRD3—Circadian rythm related genes—TP53—schizophrenia	1.61e-05	0.000114	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—HTR2C—schizophrenia	1.59e-05	0.000113	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—DRD1—schizophrenia	1.59e-05	0.000113	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—NPS—schizophrenia	1.59e-05	0.000113	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—GFAP—schizophrenia	1.59e-05	0.000113	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—NGEF—schizophrenia	1.59e-05	0.000113	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—NTS—schizophrenia	1.58e-05	0.000113	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—NPY—schizophrenia	1.58e-05	0.000112	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—ABCB1—schizophrenia	1.58e-05	0.000112	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—GRM5—schizophrenia	1.57e-05	0.000112	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—APOE—schizophrenia	1.56e-05	0.000111	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—HTR2C—schizophrenia	1.56e-05	0.000111	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—DRD1—schizophrenia	1.56e-05	0.000111	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—HTR1B—schizophrenia	1.56e-05	0.000111	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—OXT—schizophrenia	1.56e-05	0.000111	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—NTS—schizophrenia	1.55e-05	0.00011	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—DRD3—schizophrenia	1.54e-05	0.00011	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—APOA1—schizophrenia	1.54e-05	0.00011	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—GSTM1—schizophrenia	1.53e-05	0.000109	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—PLA2G4A—schizophrenia	1.53e-05	0.000109	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—SLC27A5—schizophrenia	1.53e-05	0.000109	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—ACSL6—schizophrenia	1.53e-05	0.000109	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—HTR1B—schizophrenia	1.52e-05	0.000108	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—OXT—schizophrenia	1.52e-05	0.000108	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—TLE3—schizophrenia	1.52e-05	0.000108	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—GSK3B—schizophrenia	1.51e-05	0.000107	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—DRD3—schizophrenia	1.51e-05	0.000107	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—HTR1A—schizophrenia	1.5e-05	0.000107	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—DRD4—schizophrenia	1.5e-05	0.000107	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—RTN4—schizophrenia	1.49e-05	0.000106	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—GRM3—schizophrenia	1.49e-05	0.000106	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—RGS4—schizophrenia	1.49e-05	0.000106	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—NPS—schizophrenia	1.48e-05	0.000105	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—HTR1A—schizophrenia	1.47e-05	0.000104	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—DRD4—schizophrenia	1.47e-05	0.000104	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—HTR6—schizophrenia	1.46e-05	0.000104	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—DAO—schizophrenia	1.46e-05	0.000104	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—RTN4—schizophrenia	1.46e-05	0.000104	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—RGS4—schizophrenia	1.46e-05	0.000104	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—GRM3—schizophrenia	1.46e-05	0.000104	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—DRD1—schizophrenia	1.45e-05	0.000103	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—HTR2C—schizophrenia	1.45e-05	0.000103	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—MTHFR—schizophrenia	1.45e-05	0.000103	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—NPS—schizophrenia	1.45e-05	0.000103	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CCK—schizophrenia	1.44e-05	0.000102	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—CNR1—schizophrenia	1.43e-05	0.000102	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—HTR6—schizophrenia	1.43e-05	0.000102	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—DRD1—schizophrenia	1.42e-05	0.000101	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—HTR2C—schizophrenia	1.42e-05	0.000101	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—MAG—schizophrenia	1.41e-05	0.0001	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—DRD3—schizophrenia	1.4e-05	9.97e-05	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—CNR1—schizophrenia	1.4e-05	9.96e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—PDE4B—schizophrenia	1.4e-05	9.94e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—PNP—schizophrenia	1.4e-05	9.94e-05	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—HTR7—schizophrenia	1.4e-05	9.93e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—MAG—schizophrenia	1.38e-05	9.82e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CCKAR—schizophrenia	1.38e-05	9.78e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—DRD3—schizophrenia	1.37e-05	9.76e-05	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—DRD2—schizophrenia	1.37e-05	9.72e-05	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—HTR7—schizophrenia	1.37e-05	9.72e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—DRD4—schizophrenia	1.36e-05	9.68e-05	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—MTHFR—schizophrenia	1.35e-05	9.61e-05	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—APOE—schizophrenia	1.35e-05	9.56e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—ADORA2A—schizophrenia	1.33e-05	9.48e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—DRD4—schizophrenia	1.33e-05	9.47e-05	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—APOA1—schizophrenia	1.33e-05	9.45e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—PLA2G4A—schizophrenia	1.31e-05	9.32e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—CNR1—schizophrenia	1.3e-05	9.24e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—NDUFV2—schizophrenia	1.3e-05	9.24e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CHRM1—schizophrenia	1.29e-05	9.18e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—FGA—schizophrenia	1.28e-05	9.09e-05	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—HTR2A—schizophrenia	1.28e-05	9.09e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—CNR1—schizophrenia	1.27e-05	9.04e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—HTR7—schizophrenia	1.27e-05	9.01e-05	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—APOE—schizophrenia	1.26e-05	8.94e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—IL3RA—schizophrenia	1.26e-05	8.94e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—NPY—schizophrenia	1.25e-05	8.86e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—NOTCH4—schizophrenia	1.25e-05	8.86e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—ATP2A2—schizophrenia	1.25e-05	8.86e-05	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—APOA1—schizophrenia	1.24e-05	8.84e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—HTR7—schizophrenia	1.24e-05	8.82e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—DRD2—schizophrenia	1.24e-05	8.82e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—IL3RA—schizophrenia	1.23e-05	8.75e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—NRG3—schizophrenia	1.23e-05	8.73e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—TLE1—schizophrenia	1.23e-05	8.73e-05	CbGpPWpGaD
Metoclopramide—DRD2—Circadian rythm related genes—TP53—schizophrenia	1.23e-05	8.73e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—PIP4K2A—schizophrenia	1.22e-05	8.68e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—GFAP—schizophrenia	1.21e-05	8.63e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—OXT—schizophrenia	1.2e-05	8.55e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—HTR1B—schizophrenia	1.2e-05	8.55e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—NRG3—schizophrenia	1.2e-05	8.54e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—TLE1—schizophrenia	1.2e-05	8.54e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Circadian rythm related genes—TP53—schizophrenia	1.2e-05	8.54e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—GRM5—schizophrenia	1.2e-05	8.53e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—GFAP—schizophrenia	1.19e-05	8.45e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—GRM5—schizophrenia	1.18e-05	8.35e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—TLE3—schizophrenia	1.16e-05	8.26e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—HTR2A—schizophrenia	1.16e-05	8.25e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—HTR1A—schizophrenia	1.16e-05	8.23e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—NPS—schizophrenia	1.14e-05	8.1e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—TLE3—schizophrenia	1.14e-05	8.09e-05	CbGpPWpGaD
Metoclopramide—HTR4—GPCR downstream signaling—AKT1—schizophrenia	1.12e-05	7.97e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—HTR2C—schizophrenia	1.12e-05	7.95e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—DRD1—schizophrenia	1.12e-05	7.95e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—CYP26B1—schizophrenia	1.11e-05	7.85e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CCK—schizophrenia	1.1e-05	7.8e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—NTRK2—schizophrenia	1.09e-05	7.73e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CCK—schizophrenia	1.07e-05	7.64e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—PDE4B—schizophrenia	1.07e-05	7.61e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CCKAR—schizophrenia	1.05e-05	7.48e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—DRD4—schizophrenia	1.05e-05	7.47e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—PDE4B—schizophrenia	1.05e-05	7.44e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CCKAR—schizophrenia	1.03e-05	7.32e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—ADORA2A—schizophrenia	1.02e-05	7.26e-05	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—AKT1—schizophrenia	1.02e-05	7.23e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—PLA2G4A—schizophrenia	1e-05	7.13e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CNR1—schizophrenia	1e-05	7.13e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—ADORA2A—schizophrenia	9.99e-06	7.1e-05	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—EP300—schizophrenia	9.95e-06	7.07e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—TPH1—schizophrenia	9.85e-06	7e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—GCLM—schizophrenia	9.85e-06	7e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—PLA2G4A—schizophrenia	9.82e-06	6.98e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—DRD2—schizophrenia	9.79e-06	6.96e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—HTR7—schizophrenia	9.79e-06	6.96e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—FGA—schizophrenia	9.79e-06	6.96e-05	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—HTR2A—schizophrenia	9.78e-06	6.95e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—FGA—schizophrenia	9.58e-06	6.81e-05	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—HTR2A—schizophrenia	9.57e-06	6.8e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—NPY—schizophrenia	9.54e-06	6.78e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—ATP2A2—schizophrenia	9.54e-06	6.78e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—NOTCH4—schizophrenia	9.54e-06	6.78e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—NPY—schizophrenia	9.33e-06	6.63e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—ATP2A2—schizophrenia	9.33e-06	6.63e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—NOTCH4—schizophrenia	9.33e-06	6.63e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—PRKD1—schizophrenia	9.26e-06	6.58e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—PRL—schizophrenia	9.25e-06	6.57e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—HTR1B—schizophrenia	9.2e-06	6.54e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—OXT—schizophrenia	9.2e-06	6.54e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—HTR1B—schizophrenia	9.01e-06	6.4e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—OXT—schizophrenia	9.01e-06	6.4e-05	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—EP300—schizophrenia	8.9e-06	6.32e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—HTR2A—schizophrenia	8.88e-06	6.31e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—HTR1A—schizophrenia	8.86e-06	6.3e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—NPS—schizophrenia	8.72e-06	6.2e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—HTR2A—schizophrenia	8.69e-06	6.18e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—HTR1A—schizophrenia	8.67e-06	6.16e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—S100B—schizophrenia	8.62e-06	6.12e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—HTR2C—schizophrenia	8.56e-06	6.08e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—DRD1—schizophrenia	8.56e-06	6.08e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—NPS—schizophrenia	8.54e-06	6.07e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—DRD1—schizophrenia	8.37e-06	5.95e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—HTR2C—schizophrenia	8.37e-06	5.95e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—NTRK2—schizophrenia	8.32e-06	5.91e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—DRD3—schizophrenia	8.29e-06	5.89e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—ERBB4—schizophrenia	8.24e-06	5.86e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—NTRK2—schizophrenia	8.14e-06	5.79e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—DRD3—schizophrenia	8.11e-06	5.76e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—DRD4—schizophrenia	8.04e-06	5.72e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—DRD4—schizophrenia	7.87e-06	5.59e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—PLA2G4A—schizophrenia	7.75e-06	5.51e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—GAPDH—schizophrenia	7.73e-06	5.49e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CNR1—schizophrenia	7.68e-06	5.46e-05	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—EP300—schizophrenia	7.67e-06	5.45e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—CLOCK—schizophrenia	7.66e-06	5.44e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—NRG1—schizophrenia	7.61e-06	5.41e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—MEF2C—schizophrenia	7.54e-06	5.36e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CNR1—schizophrenia	7.52e-06	5.34e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—HTR7—schizophrenia	7.49e-06	5.33e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—CACNB2—schizophrenia	7.47e-06	5.31e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—TPH2—schizophrenia	7.47e-06	5.31e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—DPYD—schizophrenia	7.34e-06	5.22e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—HTR7—schizophrenia	7.33e-06	5.21e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—DRD2—schizophrenia	7.33e-06	5.21e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—YWHAZ—schizophrenia	7.29e-06	5.18e-05	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—EP300—schizophrenia	7.17e-06	5.1e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—ERBB3—schizophrenia	7.13e-06	5.06e-05	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—TP53—schizophrenia	7.12e-06	5.06e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—PRL—schizophrenia	7.08e-06	5.03e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—PRL—schizophrenia	6.93e-06	4.92e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—HTR2A—schizophrenia	6.86e-06	4.87e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—CACNA1C—schizophrenia	6.83e-06	4.85e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—PIK3C2A—schizophrenia	6.65e-06	4.73e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—S100B—schizophrenia	6.59e-06	4.69e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—S100B—schizophrenia	6.45e-06	4.59e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—APOE—schizophrenia	6.38e-06	4.53e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—ERBB4—schizophrenia	6.31e-06	4.48e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—APOA1—schizophrenia	6.3e-06	4.48e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—ERBB4—schizophrenia	6.17e-06	4.39e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—ESR1—schizophrenia	6.09e-06	4.33e-05	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—AKT1—schizophrenia	6.01e-06	4.27e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—SNAP25—schizophrenia	5.97e-06	4.24e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—PLA2G4A—schizophrenia	5.93e-06	4.21e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—NRG1—schizophrenia	5.82e-06	4.14e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—PLA2G4A—schizophrenia	5.8e-06	4.12e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—MEF2C—schizophrenia	5.77e-06	4.1e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—NRG1—schizophrenia	5.7e-06	4.05e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—MEF2C—schizophrenia	5.65e-06	4.01e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—YWHAZ—schizophrenia	5.58e-06	3.96e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—GSK3B—schizophrenia	5.52e-06	3.92e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—YWHAZ—schizophrenia	5.46e-06	3.88e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—ERBB3—schizophrenia	5.45e-06	3.88e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—CYP1A2—schizophrenia	5.4e-06	3.84e-05	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—AKT1—schizophrenia	5.38e-06	3.82e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—ERBB3—schizophrenia	5.34e-06	3.79e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—TH—schizophrenia	5.32e-06	3.78e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—HTR2A—schizophrenia	5.25e-06	3.73e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—HTR2A—schizophrenia	5.14e-06	3.65e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—APOE—schizophrenia	4.88e-06	3.47e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—APOA1—schizophrenia	4.82e-06	3.43e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—APOE—schizophrenia	4.78e-06	3.39e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—APOA1—schizophrenia	4.72e-06	3.35e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—ESR1—schizophrenia	4.66e-06	3.31e-05	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—AKT1—schizophrenia	4.63e-06	3.29e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—ESR1—schizophrenia	4.56e-06	3.24e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—COMT—schizophrenia	4.52e-06	3.21e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—GSTP1—schizophrenia	4.5e-06	3.2e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—MAOA—schizophrenia	4.49e-06	3.19e-05	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—AKT1—schizophrenia	4.33e-06	3.08e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—ABCB1—schizophrenia	4.26e-06	3.03e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—GSK3B—schizophrenia	4.23e-06	3e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—GSTM1—schizophrenia	4.14e-06	2.94e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—PLA2G4A—schizophrenia	4.14e-06	2.94e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—GSK3B—schizophrenia	4.14e-06	2.94e-05	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—AKT1—schizophrenia	4.09e-06	2.91e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—AKT1—schizophrenia	3.72e-06	2.64e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—MTHFR—schizophrenia	3.66e-06	2.6e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—EP300—schizophrenia	3.63e-06	2.58e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—APOE—schizophrenia	3.4e-06	2.42e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—APOA1—schizophrenia	3.36e-06	2.39e-05	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—AKT1—schizophrenia	3.13e-06	2.23e-05	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—AKT1—schizophrenia	3.07e-06	2.18e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—AKT1—schizophrenia	2.84e-06	2.02e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—AKT1—schizophrenia	2.78e-06	1.98e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—EP300—schizophrenia	2.78e-06	1.98e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—EP300—schizophrenia	2.72e-06	1.93e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—TP53—schizophrenia	2.6e-06	1.85e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—AKT1—schizophrenia	2.2e-06	1.56e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—TP53—schizophrenia	1.99e-06	1.41e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—TP53—schizophrenia	1.95e-06	1.38e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—EP300—schizophrenia	1.94e-06	1.38e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—AKT1—schizophrenia	1.68e-06	1.19e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—AKT1—schizophrenia	1.64e-06	1.17e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—AKT1—schizophrenia	1.17e-06	8.33e-06	CbGpPWpGaD
